ES418575A1 - Un procedimiento para preparar un compuesto seleccionado delgrupo de antimeros y mezclas recenicas de los mismos. - Google Patents
Un procedimiento para preparar un compuesto seleccionado delgrupo de antimeros y mezclas recenicas de los mismos.Info
- Publication number
- ES418575A1 ES418575A1 ES418575A ES418575A ES418575A1 ES 418575 A1 ES418575 A1 ES 418575A1 ES 418575 A ES418575 A ES 418575A ES 418575 A ES418575 A ES 418575A ES 418575 A1 ES418575 A1 ES 418575A1
- Authority
- ES
- Spain
- Prior art keywords
- derivatives
- novel
- prostaglandin derivatives
- difluoromethylene
- prostaglandin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003180 prostaglandins Chemical class 0.000 title abstract 3
- LTVOKYUPTHZZQH-UHFFFAOYSA-N difluoromethane Chemical group F[C]F LTVOKYUPTHZZQH-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 abstract 1
- -1 difluoromethylene group Chemical group 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000004702 methyl esters Chemical class 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 abstract 1
- 230000002997 prostaglandinlike Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/17—Unsaturated ethers containing halogen
- C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/516—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of nitrogen-containing compounds to >C = O groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28733372A | 1972-09-08 | 1972-09-08 | |
| US379127A US3867423A (en) | 1972-09-08 | 1973-07-13 | Difluoromethylene substituted prostaglandin derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES418575A1 true ES418575A1 (es) | 1977-05-01 |
Family
ID=26964400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES418575A Expired ES418575A1 (es) | 1972-09-08 | 1973-09-07 | Un procedimiento para preparar un compuesto seleccionado delgrupo de antimeros y mezclas recenicas de los mismos. |
Country Status (13)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5120803U (US06582424-20030624-M00016.png) * | 1974-07-31 | 1976-02-16 | ||
| US4001295A (en) * | 1975-06-23 | 1977-01-04 | Syntex (U.S.A.) Inc. | 11,12-difluoromethylene substituted prostanoic and prost-5-cis-enoic acid derivatives |
| US4188329A (en) * | 1975-09-08 | 1980-02-12 | Abbott Laboratories | Intermediates for the preparation of prostaglandins and prostaglandin analogs from a mold metabolite |
| EP0329184A3 (en) * | 1988-02-19 | 1990-05-23 | Neorx Corporation | Antimers and antimeric conjugation |
-
1973
- 1973-07-13 US US379127A patent/US3867423A/en not_active Expired - Lifetime
- 1973-08-15 IL IL42995A patent/IL42995A/xx unknown
- 1973-08-15 CA CA179,099A patent/CA1041496A/en not_active Expired
- 1973-08-29 GB GB4073673A patent/GB1414881A/en not_active Expired
- 1973-09-05 DE DE19732344740 patent/DE2344740A1/de active Pending
- 1973-09-06 CH CH1282273A patent/CH602626A5/xx not_active IP Right Cessation
- 1973-09-06 CH CH227577A patent/CH595343A5/xx not_active IP Right Cessation
- 1973-09-06 CH CH227477A patent/CH596167A5/xx not_active IP Right Cessation
- 1973-09-06 CH CH227377A patent/CH595342A5/xx not_active IP Right Cessation
- 1973-09-07 JP JP48101000A patent/JPS4992055A/ja active Pending
- 1973-09-07 ES ES418575A patent/ES418575A1/es not_active Expired
- 1973-09-07 AT AT778173A patent/AT340071B/de not_active IP Right Cessation
- 1973-09-07 FR FR7332349A patent/FR2198754B1/fr not_active Expired
- 1973-09-07 NL NL7312390A patent/NL7312390A/xx not_active Application Discontinuation
-
1976
- 1976-12-02 HK HK752/76*UA patent/HK75276A/xx unknown
-
1977
- 1977-12-30 MY MY75/77A patent/MY7700075A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2344740A1 (de) | 1974-03-21 |
| HK75276A (en) | 1976-12-10 |
| CA1041496A (en) | 1978-10-31 |
| IL42995A0 (en) | 1973-11-28 |
| JPS4992055A (US06582424-20030624-M00016.png) | 1974-09-03 |
| ATA778173A (de) | 1977-03-15 |
| IL42995A (en) | 1978-03-10 |
| GB1414881A (en) | 1975-11-19 |
| FR2198754B1 (US06582424-20030624-M00016.png) | 1976-09-03 |
| NL7312390A (US06582424-20030624-M00016.png) | 1974-03-12 |
| FR2198754A1 (US06582424-20030624-M00016.png) | 1974-04-05 |
| MY7700075A (en) | 1977-12-31 |
| CH595342A5 (US06582424-20030624-M00016.png) | 1978-02-15 |
| CH596167A5 (US06582424-20030624-M00016.png) | 1978-02-28 |
| US3867423A (en) | 1975-02-18 |
| AU5974773A (en) | 1975-03-06 |
| AT340071B (de) | 1977-11-25 |
| CH602626A5 (US06582424-20030624-M00016.png) | 1978-07-31 |
| CH595343A5 (US06582424-20030624-M00016.png) | 1978-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES449162A1 (es) | Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico. | |
| GB1515414A (en) | 2 descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-omega-pentanorprostaglandins | |
| US4161605A (en) | ω-Aryl-cis-13-PGE compounds | |
| GB1269657A (en) | Prostaglandin analogues, their preparation and pharmaceutical compositions containing them | |
| SE7604409L (sv) | Nya prostaglandin-acetylenanaloger och sett att framstella desamma | |
| US4097508A (en) | Cis-4,5-didehydro-13,14 dihydro-9, dioxy PGF compounds | |
| US4122098A (en) | CIS-4,5-Didehydro-9-deoxy-9,10-didehydro-PGD1 compounds | |
| IL33949A (en) | 5,6-dehydro pge2,pgf2alpha and pgf2beta derivatives | |
| US4124621A (en) | Cis-4,5-didehydro-12,13(e)-didehydro-13,14-dihydro-9-deoxy-PGD1 compounds | |
| ES418575A1 (es) | Un procedimiento para preparar un compuesto seleccionado delgrupo de antimeros y mezclas recenicas de los mismos. | |
| GB1285400A (en) | Esters of substituted anthranilic acid | |
| JPS528035A (en) | Preparation of polyolefin composition for coating | |
| GB1424417A (en) | Prostaglandin intermediates and their preparation | |
| GB1496491A (en) | Dihydroergopeptine derivatives | |
| ES427614A1 (es) | Un procedimiento para producir nuevos derivados de prosta- glandinas. | |
| US4065633A (en) | 2,2-Difluoro-13,14-dihydro-PGA1 analogs | |
| US4065628A (en) | 17-Phenyl-18,19,20-trinor-cis-4,5-didehydro-PGE, compounds | |
| US4130591A (en) | 2-Decarboxy-2-hydroxy-methyl-13,14-didehydro-16-phenoxy PGF compounds | |
| GB1480286A (en) | 11-substituted-11-deoxy-pge analogues | |
| US4321370A (en) | 2,5-Inter-o-phenylene-3,4-dinor-6,9α-epoxy-6β-PGF1 compounds | |
| US4235788A (en) | 6,7-Didehydro- or 7,8-didehydro-PGI1 acyl-substituted phenyl esters | |
| US4041066A (en) | 4,5-Cis-didehydro-PGE1 compounds | |
| ES430420A1 (es) | Procedimiento para la preparacion de derivados de propanol. | |
| GB1529852A (en) | 8-azaprostaglandins and process for the preparation thereof | |
| US4207420A (en) | 2,2-Difluoro-PGF1 analogs |